A systematic review highlights the lack of nutritional reporting in diabetes and obesity drug trials, raising concerns about potential deficiencies and adverse health effects among users.
Analysis & Context
A systematic review highlights the lack of nutritional reporting in diabetes and obesity drug trials, raising concerns about potential deficiencies and adverse health effects among users. Australian researchers warn GLP-1 weight-loss drugs may raise risk of scurvy, wounds ‘failing to heal’ properly. Stay informed with the latest developments and expert analysis on this important story.
A systematic review highlights the lack of nutritional reporting in diabetes and obesity drug trials, raising concerns about potential deficiencies and adverse health effects among users.